Table 1 Comparisons of clinical characteristics between genders

No., patients/eyes

51/55

229/243

/

Affected eye, OD/OS

25/30

121/122

0.56

Bilaterality, bilateral/unilateral

4/47

14/215

0.75

Age of onset, years

65.2 ± 5.9

63.8 ± 5.1

0.17

Duration of symptoms, months

9.65 ± 1.42

9.29 ± 0.68

0.51

Stage, stage3/stage4

29/26

163/80

0.045 *

 Affected eye

1.03 ± 0.33(20/167)

1.08 ± 0.39(20/167)

0.51

 Fellow eye

0.21 ± 0.34(20/27)

0.19 ± 0.29(20/27)

0.74

 Affected eye

14.5 ± 3.0

15.6 ± 3.2

0.022 *

 Fellow eye

15.1 ± 3.4

15.3 ± 3.1

0.71

 Affected eye

23.6 ± 0.7

23.2 ± 0.9

0.001 *

 Fellow eye

23.7 ± 0.8

23.2 ± 1.0

< 0.001*

Combined cataract surgery, Yes/No

47/6

212/19

0.47

Tamponade, air/gas

35/18

133/98

0.26

Follow-up, months

5.63 ± 4.47

8.00 ± 7.07

0.08

Primary closure rate

96.2%

91.3%

0.39

Highest post-operative BCVA, Log MAR (Snellen)

0.34 ± 0.34(20/36)

0.38 ± 0.33 (20/39)

0.23

Recovery duration, months

4.72 ± 3.98

7.52 ± 7.33

0.024 *